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REVIEW
From the epidemiology of hepatitis  
E virus (HEV) within the swine reservoir  
to public health risk mitigation strategies:  
a comprehensive review
Morgane Salines1,2* , Mathieu Andraud1,2 and Nicolas Rose1,2
Abstract 
Hepatitis E virus (HEV) is the causative agent of hepatitis E in humans, an emerging zoonosis mainly transmitted via 
food in developed countries and for which domestic pigs are recognised as the main reservoir. It therefore appears 
important to understand the features and drivers of HEV infection dynamics on pig farms in order to implement HEV 
surveillance programmes and to assess and manage public health risks. The authors have reviewed the international 
scientific literature on the epidemiological characteristics of HEV in swine populations. Although prevalence estimates 
differed greatly from one study to another, all consistently reported high variability between farms, suggesting the 
existence of multifactorial conditions related to infection and within-farm transmission of the virus. Longitudinal 
studies and experimental trials have provided estimates of epidemiological parameters governing the transmission 
process (e.g. age at infection, transmission parameters, shedding period duration or lag time before the onset of an 
immune response). Farming practices, passive immunity and co-infection with immunosuppressive agents were 
identified as the main factors influencing HEV infection dynamics, but further investigations are needed to clarify the 
different HEV infection patterns observed in pig herds as well as HEV transmission between farms. Relevant surveil-
lance programmes and control measures from farm to fork also have to be fostered to reduce the prevalence of 
contaminated pork products entering the food chain.
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1 Introduction
Hepatitis E virus (HEV) is a non‑enveloped single‑
stranded RNA virus. It is transmitted via the faecal‑oral 
route and causes acute hepatitis in humans, clinical signs 
being similar to hepatitis A infection but usually more 
severe [1]. Chronic cases have also been described in 
immunocompromised patients [2]. There are four HEV 
genotypes: genotypes 1 and 2 are specific to humans 
and are currently circulating in Asia, Africa and Central 
America in epidemic waves linked to the consumption of 
contaminated water [3]. Genotypes 3 and 4 are responsi‑
ble for sporadic autochthonous human cases in developed 
countries and are common to humans and other animal 
species [3, 4]. Genotype 3 in particular is highly prevalent 
in wild and domestic pigs, but the infection does not lead 
to a clinical disease [5]. Swine and human HEV strains are 
genetically very close, and cross‑species transmission has 
been proved [6]. Moreover, a number of sporadic autoch‑
thonous cases have been related to the consumption of 
raw or undercooked pork products, especially liver‑based 
products [7–9]. Thus, hepatitis E is considered to be an 
emerging zoonosis, domestic pigs being recognised as its 
main reservoir in industrialised countries [4, 10]. It is cru‑
cial to fully understand the conditions related to pig farm 
infection and HEV transmission dynamics within the 
swine population in order to limit the risk of introducing 
contaminated products into the food chain.
Several prevalence studies have been carried out in pig 
herds, either on a farm or individual scale. Prevalence 
estimates derived from either virological or serological 
analyses have evidenced wide differences depending on 
the country and year of study. However, the available data 
are difficult to compare since the pigs’ age and produc‑
tion stage vary according to studies, as do the HEV detec‑
tion methods and biological matrix used for analyses. 
Moreover, the precision of the different estimates var‑
ies greatly between studies owing to huge differences in 
sample sizes. Even within the same study, the individual 
and farm‑scale prevalences observed are also highly het‑
erogeneous. This wide dispersion suggests the existence 
of various infection dynamics linked to farm‑specific risk 
factors which have only been sporadically investigated 
to date. Observational studies mainly report the impli‑
cation of farming practices in terms of hygiene, bios‑
ecurity and rearing conditions. Complementary to this 
approach, mathematical modelling studies, based either 
on experimental trials or longitudinal studies on infected 
farms have helped reveal new insights on HEV infection 
dynamics.
It is important to explore the epidemiological charac‑
teristics of HEV on pig farms for several purposes, e.g. 
to set up a surveillance programme, or identify control 
measures to manage the risk of HEV infection and trans‑
mission with the ultimate aim of reducing the prevalence 
of HEV‑containing livers at the slaughterhouse. Informa‑
tion available from published papers has therefore been 
comprehensively gathered to identify key patterns of HEV 
infection as well as knowledge gaps and research needs. 
We have specifically focused our study on the epidemio‑
logical characteristics of the virus in domestic pigs and 
their products, since other aspects of this zoonosis have 
already been reviewed in various papers. The scope of this 
review thus covers prevalence, risk factors, transmission 
routes and infection dynamics on pig farms, surveillance 
and control strategies throughout the pork chain.
2  HEV prevalence in farmed pigs
It is crucial to know the prevalence of HEV on pig farms 
so as to be able to assess the health situation of the pig 
population and thus the risk to public health. We counted 
86 studies (from 43 different countries) addressing HEV 
prevalence in farmed pigs. These studies are summa‑
rised in Additional file 1 [5, 11–21, 24, 47, 57, 66, 70–73, 
79–139]. Various methods were used for data collection: 
samples were collected from slaughterhouses, randomly‑
selected or specifically‑selected farms, or from serum/
faeces/organ banks. Some studies were conducted at a 
given point in time, leading to an instantaneous preva‑
lence estimate, whereas others were retrospective and 
estimated the prevalence from sera collected over a 
given period of time. The number of farms varied from 
1 to 2 001; the number of samples from 40 to 6 565. Pigs 
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included in the studies differed in age and rearing con‑
ditions (family‑scale or large‑scale farms, organic or 
industrial production, for example). Little information 
was available on the swine breed or strain. Prevalence 
was investigated either on a farm or individual level. The 
virus was sought in several different biological materi‑
als, including various organs (e.g. the intestines or liver), 
serum, faeces, bile and caecal content. Individual or 
pooled samples were processed using RT‑PCR, nested 
RT‑PCR, real‑time RT‑PCR or antigen detection. The 
serological response to HEV infection was assessed by 
detection of anti‑HEV antibodies (IgG, IgM or IgA) using 
ELISA tests with specificity ranging from 85 to 100% and 
sensitivity from 50 to 100%. The viral strains detected 
belonged either to genotype 3 or genotype 4.
2.1  Farm‑scale prevalence
2.1.1  Farm‑scale seroprevalence
Farm‑scale seroprevalence reported in 15 studies ranged 
from 30 to 98% (Additional file 1). For instance, in a study 
conducted in France in 2011, 65% of the 186 randomly‑
selected farms were found to have at least one seroposi‑
tive animal (95% confidence interval 57–74) [5]. The 
serological prevalence was even higher in a retrospective 
study conducted in Spain, 204 out of 208 farms (98%, 95% 
CI 96.1–99.9) having at least one anti‑HEV IgG‑positive 
pig [11]. Similarly, in a retrospective study recently car‑
ried out in Norway, anti‑HEV IgG were detected in 90% 
(137/153) of the herds [12].
2.1.2  Farm‑scale virological prevalence
Farm‑scale virological prevalence reported in 25 studies 
ranged from 10 to 100% (Additional file 1). Widen et al. 
detected HEV‑RNA in swine faeces from 17 out of 22 
randomly‑selected farms in Sweden (72.7%) [13]. Viro‑
logical prevalence has also been estimated from HEV‑
RNA detection in sera: in 72 herds selected in Spain, at 
least one slaughtered pig tested positive for HEV‑RNA in 
serum on 47.2% of farms [14]. Regarding the presence of 
HEV RNA in liver, 24% (95% CI 17–31) of 186 randomly‑
selected pig farms had at least one positive liver in the 
French national prevalence study conducted by Rose 
et al. in 2011 [5].
2.2  Individual prevalence
2.2.1  Individual seroprevalence
Individual seroprevalence ranged from 8 to 93% in the 45 
studies analysed (Additional file 1). In France, 31% (95% 
CI 24–38) of the slaughter‑aged pigs in 2011 were found 
HEV seropositive [5]. Similarly, Jinshan et  al. detected 
52% of sampled pigs positive for anti‑HEV antibodies in 
Mongolia [15]. Crossan et al. separately tested the pres‑
ence of the different types of anti‑HEV antibodies in 
Scotland and reported that, of 176 serum samples tested, 
29% (n = 51) were anti‑HEV IgG‑positive, 36.9% (n = 65) 
anti‑HEV IgA‑positive and 29% (n = 51) anti‑HEV IgM‑
positive. Overall seroprevalence (anti‑HEV IgG+  and/
or IgA+ and/or IgM+) was 61.4% (n = 108) [16]. In the 
same region and period, individual HEV seroprevalence 
was found by Grierson et  al. to be even higher; they 
reported that 584 out of 629 pigs (92.8%) had anti‑HEV 
antibodies at the time of slaughter [17].
2.2.2  Individual virological prevalence
Individual virological prevalence ranged from 1 to 89% in 
the 69 reported studies (Additional file  1). For instance, 
the HEV genome was detected in the faeces of 42% of 274 
randomly‑selected pigs from six different swine farms in 
northern Italy [18]. HEV RNA was also detected in serum: 
Crossan et al. reported a virological prevalence of 44.4% 
in serum (72/162) [16], whereas Grierson et  al. detected 
HEV RNA in only 3% of plasma samples (22/629) in 
pigs at slaughter age [17]. In the same study, 15% of cae‑
cal contents (93/629) were found positive to HEV RNA 
[17]. Regarding the detection of HEV in liver, Rose et al. 
reported an individual prevalence of HEV RNA‑positive 
livers of 4% (95% CI 2–6) at slaughter age [5].
Both at farm and individual levels, studies carried out 
in a given country at different times or retrospectively did 
not show any significant change in prevalence estimates 
over time, suggesting that HEV was constantly circulating 
in pig farms. The marked variability in individual preva‑
lence estimates between farms is noteworthy: from 12.8 
to 72.5% in Italy [18], from 4 to 58% in Argentina [19], 
and from 5 to 90% in France [5]. This may reflect different 
infection dynamics related to farm‑specific risk factors.
2.3  Factors influencing HEV prevalence estimates
To date, few studies have reported the risk factors associ‑
ated with high HEV prevalence on pig farms. We iden‑
tified 12 studies addressing HEV risk factors, but only 
six of them quantified the impact of risk factors on HEV 
seroprevalence or on the prevalence of shedding pigs 
through odds ratio estimates (Table  1). The risk factors 
for a high HEV seroprevalence were mainly related to (1) 
farm characteristics and (2) farming practices. The farm‑
ing scale (medium‑size and family‑scale farms, linked 
to the number of pigs and sows) was identified as a risk 
factor related to HEV seroprevalence [15, 18, 20, 21]. It 
was also shown that HEV seroprevalence was signifi‑
cantly higher in organic farms than in conventional ones 
[22]. Several high‑risk rearing practices were reported, 
the main ones being late weaning, mingling practices 
at the nursery stage and poor hygiene [23]. Biosecurity 
measures such as requiring a shower upon entry were 
also found to be protective factors with respect to the 
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prevalence of faecal HEV RNA shedding [24]. A seasonal 
influence on the prevalence of HEV RNA among swine 
was also reported, with a major peak in March–April fol‑
lowed by a smaller peak in September–October [25].
European wild boars are recognized as a potential reser‑
voir of HEV [26, 27]. Moreover, some experimental stud‑
ies evidenced that HEV strains could be transmitted from 
European wild boars (Sus scrofa) to domestic pigs [26, 28, 
29]. Though no study directly related HEV prevalence in 
pig farms to contact with wild boars, they may play a poten‑
tial role in the swine HEV epidemiology in free‑ranged pig 
production units. The role of wild boars as HEV risk expo‑
sure for domestic pigs would deserve further investigation.
3  HEV infection characteristics and dynamics 
on pig farms
3.1  HEV infection features in pigs
3.1.1  Age at HEV infection and shedding
The age at infection was only sporadically reported in the 
literature, with only three studies inferring from sero‑
logical results the window within which infection took 
place. Almost all the studies conducted on pig farms only 
reported the age at shedding, and not the age at infection. 
Based on a large‑scale seroprevalence survey conducted 
in Japan, the average age at infection was estimated to 
range from 59.0 to 67.3 days with more than 80% of infec‑
tions occurring between the ages of 30 and 90 days [30]. 
The results of a longitudinal study on three French farms 
were quite different, most HEV infections occurring 
between 105 and 140 days of age [31]. Using Spanish data, 
Andraud et al. estimated the age at infection between 60.9 
and 96.6  days [32]. Based on serological data from lon‑
gitudinal studies in six pig herds, passive immunity was 
shown to delay early HEV infection of piglets by about 6 
weeks in all but one farm on which the dynamics of infec‑
tion were similar, whatever the animals’ initial serological 
status. Although the protective role of passive immunity 
cannot be denied, the latter case highlighted the strong 
interaction between farm‑specific husbandry and hygiene 
practices and the HEV transmission process [32].
HEV infection dynamics have in the majority of studies 
been described through the monitoring of shedding pigs. 
These studies showed that the prevalence of HEV RNA in 
swine faeces and serum depend on the production stage, 
i.e. the pig’s age (Additional file 2 [14, 15, 18, 21, 57, 66, 
86–89, 91–93, 95, 96, 104, 108, 109, 113, 114, 118–120, 
133, 135, 136, 140–150]). A broad shedding period from 
1.5 to 5 months of age was globally reported at farm scale. 
In most cases, the faecal shedding peak was described in 
3‑month‑old to 4‑month‑old pigs, and few animals had 
PCR‑positive faecal samples after 6  months of age. We 
performed a meta‑regression analysis using data from 31 
studies published between 2002 and 2016 which reported 
the prevalence of faecal HEV shedding or presence of 
HEV in livers depending on pig age. A weighted gener‑
alised linear mixed‑effect model with the publication as 
a random effect, using intra and inter‑study variances for 
a given age category as weight for individual studies, was 
fitted to age‑specific prevalence data. Despite marked 
variability between studies, the model showed that the 
probability of faecal shedding peaked around 90  days 
of age (Figure  1). The shedding prevalence estimate at 
185 days (a common slaughter age) was 6.1% [1.2–15.4].
Few studies have explored the factors influencing vari‑
ations in age at shedding. A longitudinal study conducted 
on three swine farms showed that HEV shedding in pigs 
which had been previously infected by Porcine Reproduc‑
tive and Respiratory Syndrome Virus (PRRSV) occurred 
later than in pigs that were PRRSV‑negative or which 
had been infected by PRRSV after HEV infection (haz‑
ard ratio = 0.49, p < 0.01) [33]. Hence, the latency period 
(delay between infection and shedding) may be affected 
by different circumstances, modifying the age at shed‑
ding. When pigs were infected intravenously, the latency 
Table 1 Quantified risk factors associated with a high HEV seroprevalence in pig farms
OR odds ratio.
Di Bartolo et al. [18] Number of sows > 1000: HEV seroprevalence = 54.2 vs 18.9%
Li et al. [21] HEV seroprevalence on family-scale farms = 90 vs 76% in large-scale farms (p < 0.01)
Jinshan et al. [15] Number of pigs > 600: HEV seroprevalence ranged from 78 to 100%, vs 0 to 29%
Hinjoy et al. [20] Medium-sized farms compared with large farms: OR 4.95 (1.79–13.70)
Presence of bird faeces inside the pig house: OR 2.87 (1.07–7.71)
Walachowski et al. [23] Duration of the nursery down period < 4 days: OR 1.7 (1.04–2.9)
Distance between pit manure and slatted floor in fattening premises < 80 cm: OR 1.9 (1.1–3.5)
Mingling of pigs from different premises between farrowing and nursery stages: OR 1.8 (1.1–2.9)
Pen size in nursery rooms > 26 pigs/pen: OR 2.4 (1.2–4.8)
Rutjes et al. [22] HEV seroprevalence on organic farms = 89 vs 72% on conventional farms (p = 0.04)
HEV seroprevalence on free-range farms = 76 vs 72% on conventional farms (p = 0.06)
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period measured by Bouwknegt et  al. was 3  days, com‑
pared to 6.9  days [5.82–7.9] when inoculated orally [34, 
35]. According to the results of a co‑infection trial, the 
HEV latency period was extended by a factor of 1.9 in the 
event of PRRSV co‑infection (12.9 days [12.8–14.4]) [36]. 
In a recent longitudinal study on two Finnish farms identi‑
fied as HEV‑positive, piglets started to shed HEV between 
7 and 12 weeks of age. Of these, 62.5% only began shed‑
ding HEV between the ages of 10 and 12 weeks [37]. The 
authors suspected that the difference in age of the onset 
of infection or shedding may have resulted from the 
quantity and/or quality of colostrum providing the pig‑
lets with maternal antibodies. The quantity of virus par‑
ticles ingested may also modify the course of infection at 
the individual level. The minimal per os infectious dose is 
still not well known. However, it has been estimated that 
oral infection would require about 20 mg of faeces per day 
containing on average  108 genome equivalent (GE) per 
gram over three consecutive days to achieve a 50% proba‑
bility of infection [38]. These results were then confirmed 
by testing different infection doses for inoculation by the 
oral route: a minimal viral load of  106 GE was necessary 
for pigs to be orally infected and to shed and transmit the 
virus [35]. Below that level, only sporadic shedding was 
detected, with no transmission to sentinel piglets.
3.1.2  Shedding duration and quantity of virus particles shed
Shedding duration is not easy to measure on farms as 
it requires an individual follow‑up of pigs. The HEV 
shedding period was estimated at around 27 days in two 
studies carried out on commercial pig farms in Europe 
[33, 39]. Data from three pig herds evidenced a huge vari‑
ation in the infection dynamics according to the farms, 
with some batches exhibiting late and short‑term infec‑
tions, while others had early and long‑term shedding 
periods [31]. When pigs were experimentally infected by 
the intravenous route, shedding lasted from 13 to 49 days 
depending on the viral dose inoculated [34], whereas 
an HEV infection trial described a shedding duration of 
9.7  days [8.2–11.2] when pigs were orally infected [35]. 
This experimental estimate was lower than shedding 
durations observed on farms, suggesting the existence of 
factors influencing duration of the shedding period. One 
of them may be other pathogens co‑infecting pigs. For 
instance, one trial showed that a PRRSV/HEV co‑infec‑
tion dramatically extended the shedding period by a fac‑
tor of 5 to 48.6 vs 9.7 days [36].
Few data are available on the quantity of virus particles 
shed by infected animals. In field conditions, one study 
carried out in two pig herds in Japan reported an HEV 
load in faeces of between  103.8 and  106 GE/g throughout 
the pigs’ life [40]. Similarly, the quantity of HEV particles 
shed was evaluated between  104 and  106 GE/g of faeces 
in an experimental trial involving 18 pigs that had been 
orally infected [35]. When pigs were co‑infected with 
PRRSV, the viral load shed increased to between  105 and 
 108 GE/g of faeces, and the accumulation of HEV in the 
environment was significantly higher too [36].
3.1.3  Humoral immune response
Fourteen studies investigated the humoral response of 
pigs following HEV infection (Additional file 2). In a lon‑
gitudinal study carried out on six Spanish farms [41], IgM 
antibodies were first detected at 7  weeks of age in five 
farms and at 13 weeks of age in only one farm, whereas 
IgG antibodies were firstly observed at 13  weeks of age 
in four farms and at 18  weeks of age in the two other 
farms. At slaughter age (26 weeks), IgG antibodies were 
detected in 50 to 100% of pigs on five out of the six farms. 
In the study conducted by de Deus et al. [42], IgG anti‑
bodies were detected later (around 15  weeks), whereas 
IgA and IgM appeared at around 12 weeks. Similarly to 
the previous study, IgG antibodies were detected up to 
the slaughter age (22 weeks), whereas IgA and IgM only 
remained for 4–7 weeks.
Thanks to field data collected in Japan, Satou and 
Nishiura estimated the time required for seroconver‑
sion at 25  days (95% CI 20.9, 31.3) [30]. Similarly, the 
time to HEV seroconversion was estimated at 26.3 days 
in an experimental study and it was shown that co‑infec‑
tion with PRRSV delayed the time to seroconversion to 
43.1 days, increasing the lag to seroconversion by a factor 
Figure 1 Predicted HEV prevalence in faeces according to 
animal age. The virological prevalence data (faecal shedding or 
presence in livers) depending on age (obtained from 31 published 
studies) were used to construct a meta-regression (generalised linear 
mixed-effect model) taking into account the respective weights of 
publications calculated using the inverse of the sum of inter-study 
and intra-study variance for a given age category. The mean pre-
dicted response of the model (black line) and its confidence interval 
(red dashed lines) are presented in this figure. The size of the points is 
proportional to the weight of the study.
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of 1.6 [36]. The presence of maternal antibodies was also 
found to delay seroconversion in piglets [40, 43]. The time 
taken for maternally‑derived antibodies to wane depends 
on the quantity of the initial intake of colostral antibodies 
[41], which is itself related to the sow’s age [44] and HEV 
immune status. Passively acquired IgG remained detect‑
able up to 9 weeks of age in piglets born to highly HEV‑
seropositive sows, compared to 1–3 weeks in piglets born 
to sows with weak anti‑HEV immunity [42].
3.1.4  HEV viraemia
The natural course of infection in pigs involves infection 
at around 8–12  weeks of age coinciding with declining 
maternal antibodies, with a generally short viraemia last‑
ing from 1–2 weeks followed by a more prolonged period 
of viral shedding in the faeces (Additional file  2). How‑
ever, longer viraemia periods have also been reported, 
especially in the case of late HEV infections in pigs, pos‑
sibly lasting up to slaughter age (Additional file  2). In 
an experimental infection study, Sanford et al. observed 
more prolonged periods of viraemia in some pigs, and 
one pig was continuously viraemic for 12  weeks post‑
infection [45]. A study in Scotland showed that 44.4% of 
pigs tested were viraemic at slaughter age [16], whereas 
another study conducted in the UK only reported 3% of 
viraemic pigs at slaughter age [17]. Maternally‑derived 
antibodies were found to delay the onset of viraemia [40]. 
Furthermore, the amount of HEV RNA in the serum 
was found to be lower than that in the faeces, the high‑
est serum HEV RNA titre being on day 90 in a pig from 
a litter with passive immunity  (104.2  copies/mL) and on 
day 60 in a pig from a litter without passive immunity 
 (105.6 copies/mL).
3.2  Routes of HEV transmission between pigs
It has been proved that the virus is mainly shed by the 
faecal route, leading to an accumulation of HEV in the 
pigs’ environment at all production stages on infected 
farms, as well as in manure pits [46]. Depending on the 
type of floor (litter or slatted floor), the animals are con‑
stantly in contact (more or less direct) with the environ‑
mental HEV reservoir. The virus has also been detected 
in the urine of HEV‑infected pigs [38, 47, 48], making 
urine a potential transmission route, especially given the 
considerable volume produced per day and the poten‑
tially longer viral shedding in this medium [48]. Given the 
urinary and faecal shedding routes, drinking water and/
or feed may also be indirect vectors of HEV transmission, 
especially if feeding and drinking equipment can be eas‑
ily contaminated by faeces and urine [46]. Finally, daily 
repeated contacts between pigs kept in the same pen and 
housed in a confined environment, as well as the min‑
gling of pigs at different production stages may increase 
the propagation of HEV on farms [23, 42, 49, 50]. These 
findings confirm that the faecal‑oral route is the major 
transmission route of HEV in pigs [48, 49], even if several 
trials have highlighted the difficulty in inoculating pigs 
per os [51, 52]. Indirect transmission from one pen to 
another (without any pig mingling) was found to be low 
[35].
Three‑month old and older pigs were recognised as the 
major shedding sources in farm conditions (Figure  1). 
Fernandez‑Barredo et al. showed that weaning and early 
fattening stages were critical periods for HEV shed‑
ding with respectively 45 and 60% of shedding animals 
[46]. Breeding animals also play an important role in the 
spread and persistence of HEV within pig production 
units in two ways: (1) by providing maternally‑derived 
antibodies that protect their piglets from early‑life infec‑
tion, (2) by possibly transmitting the virus via farrowing 
crates during lactation periods. Indeed, investigations 
into faecal shedding in sows around the farrowing period 
revealed prevalences ranging from 16 to 21% [41, 42, 46]. 
A high proportion of multiparous sows were found to 
shed the virus, as well as gilts and young sows but to a 
lesser extent [18]. A study recently carried out in China 
showed that farrowing sows had an approximately 2.5‑
fold higher risk of infection (OR 2.46, p  <  0.01) than 
pre‑farrowing sows [53]. Another study on Göttingen 
Minipigs in the context of xenotransplantation safety 
detected HEV in the sera of three sows 6 days after deliv‑
ery and in their offspring [54]. Finally, in a longitudinal 
study on three pig farms, piglets from two farms shed the 
virus as early as the lactation phase in farrowing facilities 
[31]. Thus, horizontal transmission between sows and 
their piglets may occur in the early stage of a piglet’s life. 
Moreover, sows may transmit the virus to the foetus by 
the transplacentary route should viraemia occur during 
gestation, viral RNA having been detected in the livers 
of aborted fœtuses [55]. However, these results are still 
controversial, since one experimental study did not show 
any vertical transmission after intravenous inoculation 
of HEV to pregnant gilts [56]. Nevertheless, it cannot be 
excluded that breeding animals may constitute an HEV 
reservoir on infected farms, periodically shedding the 
virus according to changes in their immune status due 
to physiological conditions (pregnancy, farrowing). Sows 
may thus maintain viral propagation in swine herds.
3.3  Quantitative data on HEV transmission
The persistence of a virus on farms is linked to (1) the 
intrinsic ability of the virus to remain in the animals’ 
environment, (2) the possibility of regular reintroduc‑
tions of the virus onto farms and (3) the ability of the 
virus to survive and spread in the population. This last 
criterion can be studied through the basic reproduction 
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number (R0) of the virus, which measures the number of 
secondary infections due to one infectious pig during its 
entire shedding period in a fully susceptible population. 
The higher the basic reproduction number, the easier it 
is for the virus to spread and the greater its ability to stay 
within the population. Using a large‑scale seroprevalence 
survey dataset from Japanese pig farms, Satou and Nishi‑
ura estimated the HEV R0 between 4.02 and 5.17, mean‑
ing that one infectious animal could theoretically infect 
four to five other pigs during its infectious period [30]. 
Based on an experimental trial carried out in the Neth‑
erlands, this ratio was estimated at 8.8 [34]. However, 
this assessment relied on one‑to‑one HEV transmission 
experiments, accounting for horizontal transmission by 
direct contact only. The trial by Andraud et  al. investi‑
gated the transmission of HEV from pigs inoculated by 
the oral route to pigs in direct contact (in the same pen) 
or indirect contact (in an adjacent pen) with the inocu‑
lated pigs, assuming both environmental and direct 
transmission routes [35]. Although much lower than 
previous estimates with a partial reproduction number 
of 1.41 [0.21–3.02], direct transmission alone could be 
considered as a factor fostering the infection’s persis‑
tence within a population. The quantity of virus present 
in the environment was found to play a pivotal role in the 
transmission process, strongly influencing the probabil‑
ity of infection, with a within‑pen transmission rate esti‑
mated at 2.10−6 g/GE/day [1.10−7–7.10−6]. Between‑pen 
environmental transmission occurred to a lesser extent 
(transmission rate: 7.10−8  g/GE/day [5.10−9– 3.10−7]) 
but could further generate a within‑group infection pro‑
cess. The combination of these transmission routes could 
explain the persistence and high prevalence of HEV in 
pig populations. Moreover, the transmission of HEV was 
found even enhanced in the presence of co‑infections. 
Indeed, based on a similar experimental design with pigs 
co‑infected with PRRSV, the transmission of HEV by 
direct contact was estimated to be 4.7 times higher in pigs 
co‑infected with PRRSV (direct transmission rate  =  0.70 
[1.18.10−3–3.67]). Direct transmission therefore plays a 
more important role in HEV transmission when animals 
were co‑infected and reflecting the increased quantity of 
virus particles shed [36]. The indirect transmission rate, 
considered to be the average number of animals that 
could be infected by a single genome equivalent present 
in the pen environment, was estimated at 6.59.10−6  g/
GE/day [1.43.10−10–1.27.10−4], i.e. 3.3 times higher with 
co‑infection than without. In other words, 3.3 times 
fewer virus particles were required to infect a co‑infected 
animal than an HEV‑only infected animal. The impact of 
maternally‑derived antibodies on HEV transmission was 
also assessed by modelling field‑based longitudinal data 
on HEV dynamics of infection [32]. In this study, HEV 
transmission among piglets with passive immunity was 
estimated to be 13 times lower than in fully susceptible 
animals, with a relatively marked variability between 
herds (range: 5–21).
4  Consequences of HEV infection dynamics on the 
prevalence of contaminated livers and pork 
products
4.1  Prevalence of HEV‑containing livers at the 
slaughterhouse
In the ten studies investigating the prevalence of HEV‑
containing livers in pigs of slaughter age (Table 2), all but 
one reported prevalences ranging between 0.8 and 10% 
of liver samples, but the prevalence reported in Italy was 
over 20% [57]. Two conditions are required for a high 
prevalence of HEV‑containing livers at slaughter age: (1) 
the virus has to spread massively on farms; (2) the later 
the infection occurred, the higher the risk that pigs are 
still infectious at slaughter. One study on French pig 
farms reported several risk factors, such as the slaugh‑
ter age, genetic background, lack of hygiene measures 
and origin of drinking water [23]. An experimental trial 
also showed that the co‑infection of pigs with HEV and 
PRRSV increased the likelihood of HEV‑containing liv‑
ers at slaughter time [36]. Satou and Nishiura built a 
model from field data and using a sensitivity analysis, 
they showed that a decline in the force of infection would 
postpone the infectious process to a later age, which 
would in turn heighten the risk of pork‑to‑human trans‑
mission through the consumption of infected products 
[30].
4.2  Consequences on the safety of pork products entering 
the food chain
Nine prevalence studies were conducted on marketed 
pork products (Table 3). Different kinds of pork products 
were tested, such as raw livers, sausages, figatelli, pâté, 
etc. The prevalence of contaminated pork products var‑
ied from less than 1% to more than 50% depending on the 
country and the product. The highest prevalences were 
observed in products prepared with raw pork liver [7, 
58]. No study was led on meat but, given the late virae‑
mia at slaughter age that was observed in several studies 
(see above), there may be a potential risk to public health 
linked to the consumption of raw or undercooked pork 
meat.
The presence of HEV in food products consumed raw 
or undercooked raises the question of the thermal sta‑
bility of HEV, which was addressed in three studies. 
The first one was based on heating faecal suspensions 
of HEV genotypes 1 and 2 to temperatures between 45 
and 70 °C and inoculation in a cell culture permissive to 
HEV [59]. The second study used pigs inoculated with 
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pork liver homogenates containing infectious genotype 3 
HEV heated to 56 °C for 1 h, fried for 5 min (71 °C inter‑
nal temperature) or boiled for 5  min [60]. Both studies 
showed that HEV was more likely to resist when heated 
to only 56 °C and was inactivated at temperatures higher 
than 71 °C. The third study was conducted on more com‑
plex foodstuffs prepared according to industrial reci‑
pes (liver pâté) and showed that it was necessary to heat 
the food to an internal temperature of 71  °C for 20 min 
to fully inactivate HEV [61]. To date, no information is 
available about the efficacy of drying on HEV persistence.
5  Improving HEV surveillance and control in the 
swine reservoir: from farm‑targeted actions 
to pork product control
5.1  Options for control measures on pig farms
5.1.1  HEV vaccination on farms
No commercial vaccine is currently available against 
HEV in pigs. Some theoretical work has been carried out 
to evaluate the benefits of vaccination against this zoono‑
sis, which does not have any consequences on pig health 
or the economic performance of swine herds. Using a 
modelling approach, Backer et al. tested three effects of 
vaccination: a decrease in the virus transmission rate, in 
animal susceptibility to HEV infection, and in the dura‑
tion of the infectious period [39]. As previously shown by 
Satou and Nishiura [30], a reduced transmission rate and 
susceptibility, which induces a decrease in the force of 
infection, led to an increase in the number of infectious 
animals at the slaughterhouse. When the vaccine affected 
the duration of the infectious period, the proportion of 
pigs still infectious at slaughter age was lower. Further 
work would be needed to evaluate the required efficacy 
for a vaccine to eradicate the infection and to develop the 
corresponding efficient vaccine, without forgetting con‑
siderations on interference with passive immunity, co‑
infecting pathogens and rearing practices. A cost‑benefit 
analysis of vaccine development would also be necessary, 
Table 2 Prevalence of HEV RNA in livers collected at slaughterhouses reported in ten studies
References Country No. of samples Prevalence of RNA‑positive 
livers (%) [95% CI]
Bouwknegt et al. [51] Netherlands 62 6.5 [1.8–15.7]
Rose et al. [5] France 3 715 4 [2–6]
Di Bartolo et al. [57] Italy 48 20.8
Di Bartolo et al. [68] Spain 39 3
Italy 33 6
Czech Republic 40 5
Berto et al. [67] UK 40 3
Gardinali et al. [70] Brazil 118 1.7
de Souza et al. [71] Brazil 453 1.3
Temmam et al. [72] Madagascar 250 1.2
de Paula et al. [73] Cameroon 345 0.8
Mykytczuk et al. [74] Canada 19 10.5
Table 3 Prevalence of HEV‑positive marketed pork products reported in nine studies
References Country No. of samples Prevalence of RNA‑positive pork products (%)
Yazaki et al. [75] Japan 363 1.9% of livers sold in local grocery stores
Feagins et al. [76] USA 127 11% of livers sold in local grocery stores
Colson et al. [7] France 12 58% of marketed figatelli
Wenzel et al. [77] Germany 200 4% of livers sold in butcher’s shops and grocery stores
Berto et al. [67] UK 63 10% of marketed sausages
Di Bartolo et al. [68] Spain 93 6% of marketed sausages
Czech Republic 92 0% of sausages
Italy 128 0% of sausages
Pavio et al. [58] France 394 30% of figatelli, 29% of liver sausages, 25% of quenelles, 3% of dried salted livers
Heldt et al. [78] Brazil 50 36% of marketed pâté and blood sausages
Mykytczuk et al. [74] Canada 111 47% of pork pâté, 0% of raw pork sausages
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including public health consequences in the event of 
widespread consumer exposure to contaminated pork 
products, and the economic consequences linked to a 
potential loss of consumer confidence in pork safety.
5.1.2  Control of risk factors and co‑infecting pathogens
As previously mentioned, a lack of hygiene measures and 
several farming practices (such as late weaning or min‑
gling practices at the nursery stage) were reported as 
risky for HEV transmission and persistence. Biosecurity 
and farming practices should therefore be enhanced to 
reduce HEV risks [23].
As reported previously, co‑infections with immuno‑
suppressive swine viruses — frequently observed in pig 
herds — could lead to chronic HEV infection, which 
may dramatically increase the risk of pig livers contain‑
ing HEV at slaughter time. For instance, a PRRSV/HEV 
co‑infection or a PRRSV infection prior to HEV infec‑
tion delayed HEV shedding and the onset of the anti‑
HEV humoral immune response, increased the quantity 
of virus particles shed and extended the shedding period, 
increased the direct transmission rate and HEV infec‑
tion susceptibility, and increased the proportion of HEV‑
positive livers at slaughter time [33, 36]. Thus, controlling 
intercurrent swine diseases (e.g. through PRRSV vaccina‑
tion programmes) could be a major lever in the control 
of hepatitis E. Further research is needed in this domain 
to better understand the interactions between HEV and 
immunosuppressive pathogens, including an evaluation 
of the effect of other immunosuppressive co‑infections 
frequently encountered in the field as well as non‑biotic 
components such as mycotoxins which are likely to inter‑
fere with the immune response.
5.1.3  Organisation of the pig production network
To prevent the spread of infectious agents, it is neces‑
sary to consider the pyramidal structure of the pig pro‑
duction sector and the way contacts between pig farms 
are organised [62]. Few data are available yet. A recent 
study reported the presence of HEV inside and outside 
farm buildings, on trucks and in the slaughterhouse yard, 
thus suggesting viral transmission between farms and 
throughout the production network [63]. However, fur‑
ther research is needed to (1) model the pig production 
network; (2) explain, assess and quantify the risk of HEV 
transmission between pig farms through animal intro‑
ductions (replacement) or indirect vectors.
5.2  Surveillance throughout the pork chain
To our knowledge, no uninterrupted surveillance pro‑
gramme of the swine reservoir has ever been imple‑
mented in any country. Surveillance actions could be 
implemented at different steps: on pigs at the farming 
stage or at the slaughterhouse, or on pig livers and pork 
products.
5.2.1  Monitoring of pigs on farms or at the slaughterhouse
Pig monitoring could be either serological or virological. 
(1) Serological monitoring could be a feasible large‑scale 
approach. Data are available on the intrinsic features 
of the serological tests that could be used [64, 65], but 
further comparative analysis is still needed. Indeed, 
although a single HEV serotype exists, test performance 
varies depending on the HEV genotype [65]. However, 
more and more commercial ELISA tests are available 
and geared to HEV genotype 3, which is the main one 
circulating on pig farms in Europe and the US (e.g. HEV 
ELISA 4.0  V, MP Biomedicals). Moreover, some tests 
only detect IgM whereas others detect all immunoglobu‑
lin classes. Regarding the relevance of using serological 
tests, studies revealed a significant relationship between 
within‑farm seroprevalence and the probability of detect‑
ing HEV‑positive livers on that farm [5]. Indeed, Rose 
et al. observed that the probability of viral presence in the 
liver was significantly higher on farms where seropreva‑
lence at the finishing stage was greater than 25%: OR 
6.7 [2.1–21.6]. This result suggests that farms at risk are 
those in which the virus circulates intensely and spreads 
to more than 25% of fattening pigs [66]. However, at an 
individual level, some HEV RNA‑positive pigs (detected 
in the liver) are seronegative because infection occurs 
late, not long before slaughter. This is why it appears that 
serological tests on fattening pigs from farrow‑to‑finish 
farms should be supplemented by tests on sows in order 
to clearly determine the HEV status of the farm. (2) The 
virus could also be detected in faeces as it appears that 
the virus’ presence in the liver and viral shedding are 
well correlated [31]. This surveillance action could be 
performed on farms, e.g. for a pre‑slaughter check by 
sampling several animals. It could also be done at the 
slaughterhouse, in ante mortem waiting areas.
5.2.2  Surveillance of pig livers and pork products
Many human cases in industrialised countries are related 
to the consumption of so‑called “high‑risk” products, 
i.e. pork products consumed raw or not well cooked 
and containing a high proportion of pork liver. Surveil‑
lance could therefore target those specific products (liver 
sausages, liver pâté, figatelli, etc.). To date, few detec‑
tion tests have been developed [61, 67, 68] and only one 
method for HEV detection in food has been marketed 
(HepatitisE@CeeramTools™, quantitative RT‑PCR Kits 
for food & environmental samples). The viral concen‑
tration in food is often low. Moreover, these complex 
matrices are composed of liver, fat, salt and spices that 
make detection difficult. The analysis of meat matrices 
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requires a rotary mill that is not frequently employed in 
non‑specialised laboratories. Fat removal is essential, 
but tedious and mostly manual. Analysing food products 
is more complex than analysing livers, so livers could be 
tested after mixing and before adding other ingredients. 
As the transformation steps do not affect HEV stability 
(see above), the contamination of livers may be a relevant 
indicator of the risk of human exposure to HEV.
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Figure 2 HEV surveillance and control of the swine reservoir: from farm‑targeted actions to pork product control (adapted from [69]). 
The left side of the diagram presents a number of measures to mitigate the risk of human exposure to swine HEV, with actions applying to both 
farms and foodstuffs. A certification process (green and red squares) could be implemented throughout the food chain to guarantee the absence of 
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lenges involved in implementing these measures (in red).
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5.2.3  Applications and research needs
HEV monitoring activities in the pork production chain 
are needed for several purposes: (1) to acquire an unin‑
terrupted series of prevalence data and monitor changes 
in prevalence and the virus itself (e.g. evolution of the 
prevalence of the different HEV subtypes and emergence 
of genotype 4, which is still only sporadically detected 
in Europe and the US); (2) to investigate more precisely 
HEV infection dynamics and factors influencing their 
variation; (3) to prevent contaminated livers from enter‑
ing the food chain. For that purpose, the qualification 
of farms and/or animals and/or livers with regard to 
their HEV status could be considered. A French expert 
appraisal suggested three options that could be jointly 
implemented in order to prevent HEV‑positive liver 
being used for the preparation of products containing 
raw liver [69]:
1. Qualification of HEV-free farms The farm could be 
qualified following serological testing on sampled 
animals (see above). This would enable the identifica-
tion of farms eligible to market raw livers. However, 
this approach would be costly and would require 
constant testing, since the HEV status is unlikely to 
remain stable over time. Moreover, the logistics in 
slaughterhouses would then be complex, requiring an 
additional means of keeping HEV-free animals com-
pletely separate from HEV-positive ones.
2. Real-time qualification of HEV-free batches at the 
slaughterhouse Faecal samples could be taken from a 
determined number of pigs per batch, either in the 
ante mortem waiting area or the post mortem chain. 
The batches would be released after test results on a 
just-on-time basis. The HEV status of batches would 
be precisely known and only HEV-free batches would 
be used for the preparation of products containing 
raw liver. However, the logistics for the slaughter-
house would be both complicated and costly.
3. Qualification of liver homogenates RT-PCR could be 
performed on livers or liver homogenates to deter-
mine their HEV status. This approach would be less 
expensive yet would still enable an immediate risk 
management procedure to be followed depending 
on the result of the analysis. However, in the light of 
the HEV prevalence in livers, there would be a risk of 
detecting and rejecting many liver mixes.
These three options could lead to the creation of a sepa‑
rate sector dedicated to the fabrication of foodstuffs con‑
taining raw liver. Such a certification procedure requires 
regular food control capabilities relying on effective 
analytical tools for routine use, particularly on farms, at 
processing facilities and points of sale. The effectiveness 
of the certification system also relies on the traceability 
of pork livers, and requires a reference on the product 
label for all items containing pork liver. The label should 
provide consumers with information on the possible haz‑
ards related to consumption of these products. The coex‑
istence of these two sectors may pose problems both in 
terms of logistics for the slaughterhouses and processing 
plants, and a risk of confusion for the consumer between 
products with different food safety statuses.
Whatever the qualification method, further studies 
are needed to compare the current tests, develop a ref‑
erence method and establish a sampling plan geared to 
the sector’s situation. It is also necessary to investigate 
more precisely the risk linked to pork meat in order to 
assess the need for a meat surveillance and control plan. 
Figure  2 summarises the options for control measures 
throughout the food chain, and identifies knowledge gaps 
and challenges.
6  Conclusion
The epidemiology of HEV in the swine reservoir is far 
from being fully elucidated. Though many prevalence 
studies have been carried out in numerous countries in 
the last decade, there remain knowledge gaps that still 
have to be addressed. Research needs to focus on the 
factors that could explain the huge between‑herd varia‑
tion in infection dynamics, HEV transmission between 
farms and throughout the pig production network, and 
finally the mechanisms of action and impact of inter‑
current swine diseases. Further work also needs to be 
carried out to harmonise diagnostic tests and develop 
a standard reference method to detect HEV in complex 
foodstuffs. Surveillance plans and control programmes 
have to be carefully considered to mitigate the risk of 
human exposure to HEV through the consumption of 
pork products.
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